STEVEN NAPRAWA: Open Payments
NPI 1669436341 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153,299 in 242 payments from 7 companies in 2025. Trend: 2023 $109,536 · 2024 $81,806 · 2025 $153,299
Speaker / faculty: $129,109Travel & lodging: $12,203Consulting: $7,600Food & beverage: $4,387
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 169 | $129,750 |
| ABBVIE INC. | 46 | $22,971 |
| E.R. Squibb & Sons, L.L.C. | 18 | $335 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Alkermes, Inc. | 3 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: INGREZZA, VRAYLAR, COBENFY, Auvelity, ARISTADA, SPRAVATO, CAPLYTA.
Industry payments across NY — which companies pay providers there.
